Webinar: How political events are affecting clinical trials in Ukraine
A webinar addressing the state of drug development in Ukraine despite turmoil – boasting recruitment figures higher than the US and Western Europe. NOVEMBER 13, 2014 The Ukraine has been a hot topic in the news due to the recent turmoil in the country. Even during these difficult times, drug development and clinical trials continue […]
Pharm-Olam International Celebrates 20-Year Anniversary
HOUSTON, TEXAS – November 4th, 2014. Pharm-Olam International Ltd., a multi-national, full-service CRO to biopharmaceutical and device industries is proud to celebrate 20 years of successfully helping our sponsors create a healthier world. NOVEMBER 4, 2014 HOUSTON, TEXAS – November 4th, 2014. Pharm-Olam International Ltd., a multi-national, full-service CRO to biopharmaceutical and device industries is proud […]
Pharm-Olam completes birch and grass pollen allergy studies
Pharm-Olam provided a full-service solution for two Phase II, dose escalation allergy studies, Grass Pollen & Birch Pollen. FEBRUARY 1, 2014 Pharm-Olam was contracted to provide a full-service solution for two Phase II, dose escalation allergy studies that required a total of 500 patients in Europe. With two different allergy indications, Grass Pollen and Birch […]
Pharm-Olam Expands into IsraelPharm-Olam is pleased to announce expansion into Israel. Incorporating Israel into your clinical trials offers you several benefits including:
JANUARY 13, 2014In our continued quest to reduce time and effort to bring medicines to market; Pharm-Olam is pleased to announce expansion into Israel. Pharm-Olam continues to look to increase its strategic footprint to offer our clients a greater choice to support their clinical trials. Incorporating Israel into your clinical trials offers you several benefits […]